{"entity":{"id":"04650ca6-8319-5baf-998e-ca8969dcae37","name":"DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001483686","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"as_observed":"Edges carry the date we OBSERVED them in a source registry, not a validity period. We do not currently hold ownership end dates, so a link shown here may have ended. Check the source record before relying on currency.","direct_owners":[],"holdings":[{"role":"other","share":null,"source":"SEC EDGAR","subsidiary":{"id":"36b7ec7b-c280-5d0c-961b-2a44499dc3fd","name":"AVADEL PHARMACEUTICALS PLC","type":"Company","kind":"company","identifier":"sec:0001012477"}},{"role":"tenpercentownerother","share":null,"source":"SEC EDGAR","subsidiary":{"id":"7d2efdb1-0a0d-5c94-ad59-fe2239278452","name":"ALIMERA SCIENCES INC","type":"Company","kind":"company","identifier":"sec:0001267602"}},{"role":"tenpercentownerother","share":null,"source":"SEC EDGAR","subsidiary":{"id":"ad945a36-f186-59fa-b801-2b39506284f6","name":"ALPINE IMMUNE SCIENCES, INC.","type":"Company","kind":"company","identifier":"sec:0001626199"}},{"role":"tenpercentownerother","share":null,"source":"SEC EDGAR","subsidiary":{"id":"a0ac14ce-2fa2-5888-afaa-4d29b79abd4d","name":"AUSPEX PHARMACEUTICALS, INC.","type":"Company","kind":"company","identifier":"sec:0001454189"}},{"role":"tenpercentownerother","share":null,"source":"SEC EDGAR","subsidiary":{"id":"e266421a-23a3-55f8-9ed4-831e91084e35","name":"DICERNA PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0001399529"}},{"role":"tenpercentownerother","share":null,"source":"SEC EDGAR","subsidiary":{"id":"e1e0b3e6-2d9e-542c-92fd-023aa32b157d","name":"TRIVASCULAR TECHNOLOGIES, INC.","type":"Company","kind":"company","identifier":"sec:0001432732"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (aircraft/sanctioned vessels/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing.","mcp":{"install":"npx -y @whiteintel/mcp-server","tools":["get_dossier","trace_ownership_path","check_offshore_exposure"],"note":"Call this dossier as a tool from your agent; buy in-flow with get_pricing/buy_dossier/get_payment_link."}},"source":"corpus"}